{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:45:41Z","timestamp":1780490741123,"version":"3.54.1"},"reference-count":108,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"abstract":"<jats:p>The accumulation and deposition of misfolded \u03b1-synuclein (\u03b1-Syn) aggregates in the brain is the central event in the pathogenesis of \u03b1-synucleinopathies, including Parkinson\u2019s disease, dementia with Lewy bodies, and multiple-system atrophy. Currently, the diagnosis of these diseases mainly relies on the recognition of advanced clinical manifestations. Differential diagnosis among the various \u03b1-synucleinopathies subtypes remains challenging. Misfolded \u03b1-Syn can template its native counterpart into the same misfolded one within or between cells, behaving as a prion-like seeding. Protein-misfolding cyclic amplification and real-time quaking-induced conversion are ultrasensitive protein amplification assays initially used for the detection of prion diseases. Both assays showed high sensitivity and specificity in detection of \u03b1-synucleinopathies even in the pre-clinical stage recently. Herein, we collectively reviewed the prion-like properties of \u03b1-Syn and critically assessed the detection techniques of \u03b1-Syn-seeding activity. The progress of test tissues, which tend to be less invasive, is presented, particularly nasal swab, which is now widely known owing to the global fight against coronavirus disease 2019. We highlight the clinical application of \u03b1-Syn seeding in early and non-invasive diagnosis. Moreover, some promising therapeutic perspectives and clinical trials targeting \u03b1-Syn-seeding mechanisms are presented.<\/jats:p>","DOI":"10.3389\/fnmol.2022.975619","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T05:09:56Z","timestamp":1665378596000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical application of prion-like seeding in \u03b1-synucleinopathies: Early and non-invasive diagnosis and therapeutic development"],"prefix":"10.3389","volume":"15","author":[{"given":"Jiaqi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suying","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanpeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.4103\/1947-2714.147980","article-title":"Saliva \u03b1-synuclein and a high extinction coefficient protein: A novel approach in assessment biomarkers of Parkinson\u2019s disease","volume":"6","author":"Al-Nimer","year":"2014","journal-title":"N. Am. J. Med. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1212\/wnl.0000000000003989","article-title":"Skin nerve phosphorylated \u03b1-synuclein deposits in idiopathic REM sleep behavior disorder.","volume":"88","author":"Antelmi","year":"2017","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nmeth1066","article-title":"Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein.","volume":"4","author":"Atarashi","year":"2007","journal-title":"Nat. Methods"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-021-01175-w","article-title":"Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson\u2019s disease and dementia with Lewy bodies.","volume":"9","author":"Bargar","year":"","journal-title":"Acta Neuropathol Commun"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00491-y","article-title":"Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: The first assessment of assay reproducibility between two specialized laboratories.","volume":"16","author":"Bargar","year":"","journal-title":"Mol. Neurodegener."},{"key":"B6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3233\/jpd-150680","article-title":"Prevalence of submandibular gland synucleinopathy in Parkinson\u2019s disease, dementia with lewy bodies and other lewy body disorders.","volume":"6","author":"Beach","year":"2016","journal-title":"J. Parkinsons Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1073\/pnas.0910723107","article-title":"EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity.","volume":"107","author":"Bieschke","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/acn3.50897","article-title":"alpha-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies.","volume":"6","author":"Bongianni","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-016-0655-4","article-title":"Imaging systemic dysfunction in Parkinson\u2019s disease.","volume":"16","author":"Borghammer","year":"2016","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1080\/15548627.2015.1136769","article-title":"Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases.","volume":"12","author":"Bourdenx","year":"2016","journal-title":"Autophagy"},{"key":"B11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrn3068","article-title":"Fighting neurodegeneration with rapamycin: Mechanistic insights.","volume":"12","author":"Bov\u00e9","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-021-01276-6","article-title":"Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson\u2019s disease and dementia with Lewy bodies.","volume":"9","author":"Brockmann","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/mds.27738","article-title":"Randomized phase I clinical trial of anti-\u03b1-synuclein antibody BIIB054.","volume":"34","author":"Brys","year":"2019","journal-title":"Mov. Disord."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024091","article-title":"Cell biology and pathophysiology of \u03b1-Synuclein.","volume":"8","author":"Burr\u00e9","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026159","article-title":"SNCA triplication Parkinson\u2019s patient\u2019s iPSC-derived DA neurons accumulate \u03b1-synuclein and are susceptible to oxidative stress.","volume":"6","author":"Byers","year":"2011","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","article-title":"Gut-seeded \u03b1-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice.","volume":"23","author":"Challis","year":"2020","journal-title":"Nat. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/0888-7543(95)80237-g","article-title":"The human NACP\/alpha-synuclein gene: Chromosome assignment to 4q21.3-q22 and TaqI RFLP analysis.","volume":"26","author":"Chen","year":"1995","journal-title":"Genomics"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3791\/56373","article-title":"Real-time Quaking-induced conversion assay for detection of CWD prions in fecal material.","volume":"2017","author":"Cheng","year":"2017","journal-title":"J. Vis. Exp."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1007\/s12035-015-9133-2","article-title":"Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt-Jakob Disease.","volume":"53","author":"Cramm","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-7-42","article-title":"Exosomal cell-to-cell transmission of alpha synuclein oligomers.","volume":"7","author":"Danzer","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"B22","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1471-4159.2009.06324.x","article-title":"Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology.","volume":"111","author":"Danzer","year":"2009","journal-title":"J. Neurochem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1096\/fj.10-164624","article-title":"Heat-shock protein 70 modulates toxic extracellular \u03b1-synuclein oligomers and rescues trans-synaptic toxicity.","volume":"25","author":"Danzer","year":"2011","journal-title":"FASEB J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.1016\/j.jmb.2013.08.006","article-title":"Hsp90 inhibits \u03b1-synuclein aggregation by interacting with soluble oligomers.","volume":"425","author":"Daturpalli","year":"2013","journal-title":"J. Mol. Biol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-019-0164-x","article-title":"Efficient RT-QuIC seeding activity for alpha-synuclein in olfactory mucosa samples of patients with Parkinson\u2019s disease and multiple system atrophy.","volume":"8","author":"De Luca","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"B26","doi-asserted-by":"publisher","first-page":"13010","DOI":"10.1073\/pnas.0903691106","article-title":"Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein.","volume":"106","author":"Desplats","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1212\/wnl.0000000000000316","article-title":"Skin nerve \u03b1-synuclein deposits: A biomarker for idiopathic Parkinson disease.","volume":"82","author":"Donadio","year":"2014","journal-title":"Neurology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.24567","article-title":"Skin nerve misfolded \u03b1-synuclein in pure autonomic failure and Parkinson disease.","volume":"79","author":"Donadio","year":"2016","journal-title":"Ann. Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1096\/fj.03-1449com","article-title":"Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease.","volume":"20","author":"El-Agnaf","year":"2006","journal-title":"FASEB J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/mds.27110","article-title":"Diagnostic utility of cerebrospinal fluid alpha-synuclein in Parkinson\u2019s disease: A systematic review and meta-analysis.","volume":"32","author":"Eusebi","year":"2017","journal-title":"Mov. Disord."},{"key":"B31","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/acn3.338","article-title":"Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies.","volume":"3","author":"Fairfoul","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ana.10846","article-title":"Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications.","volume":"55","author":"Farrer","year":"2004","journal-title":"Ann. Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.nbd.2019.05.002","article-title":"Detection of alpha-synuclein aggregates in gastrointestinal biopsies by protein misfolding cyclic amplification.","volume":"129","author":"Fenyi","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/srep02540","article-title":"A longitudinal study on \u03b1-synuclein in blood plasma as a biomarker for Parkinson\u2019s disease.","volume":"3","author":"Foulds","year":"2013","journal-title":"Sci. Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1089\/ars.2011.4501","article-title":"Thiol-redox signaling, dopaminergic cell death, and Parkinson\u2019s disease.","volume":"17","author":"Garcia-Garcia","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1002\/acn3.772","article-title":"\u03b1-synuclein RT-QuIC in cerebrospinal fluid of LRRK2-linked Parkinson\u2019s disease.","volume":"6","author":"Garrido","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001277","article-title":"Highly efficient protein misfolding cyclic amplification.","volume":"7","author":"Gonzalez-Montalban","year":"2011","journal-title":"PLoS Pathog."},{"key":"B38","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ncb1841","article-title":"Prions hijack tunnelling nanotubes for intercellular spread.","volume":"11","author":"Gousset","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0508-2","article-title":"Rapid and ultra-sensitive quantitation of disease-associated alpha-synuclein seeds in brain and cerebrospinal fluid by alphaSyn RT-QuIC.","volume":"6","author":"Groveman","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"B40","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nm.3457","article-title":"Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases.","volume":"20","author":"Guo","year":"2014","journal-title":"Nat. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","article-title":"Distinct \u03b1-synuclein strains differentially promote tau inclusions in neurons.","volume":"154","author":"Guo","year":"2013","journal-title":"Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/19336896.2020.1724608","article-title":"RT-QuIC-based detection of alpha-synuclein seeding activity in brains of dementia with Lewy Body patients and of a transgenic mouse model of synucleinopathy.","volume":"14","author":"Han","year":"2020","journal-title":"Prion"},{"key":"B43","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.molmed.2012.03.002","article-title":"Beyond \u03b1-synuclein transfer: Pathology propagation in Parkinson\u2019s disease.","volume":"18","author":"Hansen","year":"2012","journal-title":"Trends Mol. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1172\/jci43366","article-title":"\u03b1-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells.","volume":"121","author":"Hansen","year":"2011","journal-title":"J. Clin. Investig."},{"key":"B45","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/s1474-4422(20)30449-x","article-title":"Detection of \u03b1-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: A longitudinal observational study.","volume":"20","author":"Iranzo","year":"2021","journal-title":"Lancet Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/j.1471-4159.2010.06695.x","article-title":"Non-classical exocytosis of alpha-synuclein is sensitive to folding states and promoted under stress conditions.","volume":"113","author":"Jang","year":"2010","journal-title":"J. Neurochem."},{"key":"B47","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/mds.27646","article-title":"Comparative study of cerebrospinal fluid alpha-synuclein seeding aggregation assays for diagnosis of Parkinson\u2019s disease.","volume":"34","author":"Kang","year":"2019","journal-title":"Mov. Disord."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-019-0095-3","article-title":"Endogenous alpha-synuclein monomers, oligomers and resulting pathology: Let\u2019s talk about the lipids in the room.","volume":"5","author":"Killinger","year":"2019","journal-title":"NPJ Parkinsons Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic \u03b1-Synuclein from the gut to the brain models Parkinson\u2019s disease.","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"B50","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in longterm embryonic nigral transplants in Parkinson\u2019s disease.","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat. Med."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-021-00242-2","article-title":"Diagnostic value of skin RT-QuIC in Parkinson\u2019s disease: A two-laboratory study.","volume":"7","author":"Kuzkina","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00401-014-1265-3","article-title":"The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset.","volume":"127","author":"Levin","year":"2014","journal-title":"Acta Neuropathol."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-3-19","article-title":"In vivo silencing of alpha-synuclein using naked siRNA.","volume":"3","author":"Lewis","year":"2008","journal-title":"Mol. Neurodegener."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.569446","article-title":"Optimization of the Detection Method for Phosphorylated \u03b1-Synuclein in Parkinson Disease by Skin Biopsy.","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Neurol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/mds.28976","article-title":"Diagnostic value of salivary real-time quaking-induced conversion in Parkinson\u2019s disease and multiple system atrophy.","volume":"37","author":"Luan","year":"2022","journal-title":"Mov. Disord."},{"key":"B56","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice.","volume":"338","author":"Luk","year":"","journal-title":"Science"},{"key":"B57","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in mice.","volume":"209","author":"Luk","year":"","journal-title":"J. Exp. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1523\/jneurosci.3944-09.2010","article-title":"Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson\u2019s disease.","volume":"30","author":"Malagelada","year":"2010","journal-title":"J. Neurosci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/mds.28651","article-title":"RT-QuIC detection of pathological \u03b1-synuclein in skin punches of patients with Lewy Body Disease.","volume":"36","author":"Mammana","year":"2021","journal-title":"Mov. Disord."},{"key":"B60","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11481-019-09835-4","article-title":"Ultrasensitive detection of aggregated alpha-synuclein in glial cells, human cerebrospinal fluid, and brain tissue using the RT-QuIC assay: New high-throughput neuroimmune biomarker assay for Parkinsonian Disorders.","volume":"14","author":"Manne","year":"2019","journal-title":"J. Neuroimmune Pharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/mds.27907","article-title":"alpha-Synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson\u2019s disease patients.","volume":"35","author":"Manne","year":"","journal-title":"Mov. Disord."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1002\/mds.28242","article-title":"Blinded RT-QuIC analysis of alpha-synuclein biomarker in skin tissue from Parkinson\u2019s disease patients.","volume":"35","author":"Manne","year":"","journal-title":"Mov. Disord."},{"key":"B63","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/brain\/awaa008","article-title":"alpha-Synuclein oligomers in skin biopsy of idiopathic and monozygotic twin patients with Parkinson\u2019s disease.","volume":"143","author":"Mazzetti","year":"2020","journal-title":"Brain"},{"key":"B64","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3233\/jpd-189004","article-title":"Clinical trial highlights: Targetting alpha-synuclein.","volume":"9","author":"McFarthing","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104623","article-title":"Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagation.","volume":"134","author":"Mezias","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1093\/brain\/awz189","article-title":"Improving diagnostic accuracy of multiple system atrophy: A clinicopathological study.","volume":"142","author":"Miki","year":"2019","journal-title":"Brain"},{"key":"B67","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1126\/science.aaf3934","article-title":"\u03b22-Adrenoreceptor is a regulator of the \u03b1-synuclein gene driving risk of Parkinson\u2019s disease.","volume":"357","author":"Mittal","year":"2017","journal-title":"Science"},{"key":"B68","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00401-002-0555-3","article-title":"Lewy bodies in progressive supranuclear palsy.","volume":"104","author":"Mori","year":"2002","journal-title":"Acta Neuropathol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.neurobiolaging.2011.06.022","article-title":"Prion-like acceleration of a synucleinopathy in a transgenic mouse model.","volume":"33","author":"Mougenot","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"B70","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3233\/JPD-201983","article-title":"Detection and assessment of alpha-synuclein oligomers in the urine of Parkinson\u2019s disease patients.","volume":"10","author":"Nam","year":"2020","journal-title":"J. Parkinsons Dis."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00727-x","article-title":"Novel antibodies detect additional alpha-synuclein pathology in synucleinopathies: Potential development for immunotherapy.","volume":"12","author":"Nimmo","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"B72","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neuron.2018.09.014","article-title":"Abrogating Native \u03b1-synuclein tetramers in mice causes a L-DOPA-responsive motor syndrome closely resembling Parkinson\u2019s disease.","volume":"100","author":"Nuber","year":"2018","journal-title":"Neuron"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10789-6","article-title":"Mechanisms of enhanced aggregation and fibril formation of Parkinson\u2019s disease-related variants of \u03b1-synuclein.","volume":"12","author":"Ohgita","year":"2022","journal-title":"Sci. Rep."},{"key":"B74","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3233\/jpd-160779","article-title":"Implication of alpha-synuclein phosphorylation at S129 in Synucleinopathies: What have we learned in the last decade?","volume":"6","author":"Oueslati","year":"2016","journal-title":"J. Parkinsons Dis."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.705407","article-title":"A Phase II study to evaluate the safety and efficacy of prasinezumab in early Parkinson\u2019s disease (PASADENA): Rationale, design, and baseline data.","volume":"12","author":"Pagano","year":"2021","journal-title":"Front. Neurol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","article-title":"Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies.","volume":"557","author":"Peng","year":"2018","journal-title":"Nature"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab045","article-title":"Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies.","volume":"3","author":"Perra","year":"2021","journal-title":"Brain Commun."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/biom11060820","article-title":"RT-QuIC Using C-Terminally Truncated \u03b1-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies.","volume":"11","author":"Poggiolini","year":"2021","journal-title":"Biomolecules"},{"key":"B79","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1093\/emboj\/19.17.4425","article-title":"Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease.","volume":"19","author":"Raymond","year":"2000","journal-title":"EMBO J."},{"key":"B80","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/40876","article-title":"Molecular assessment of the potential transmissibilities of BSE and scrapie to humans.","volume":"388","author":"Raymond","year":"1997","journal-title":"Nature"},{"key":"B81","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/ana.24066","article-title":"Lewy body extracts from Parkinson disease brains trigger \u03b1-synuclein pathology and neurodegeneration in mice and monkeys.","volume":"75","author":"Recasens","year":"2014","journal-title":"Ann. Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00401-013-1160-3","article-title":"Transfer of human \u03b1-synuclein from the olfactory bulb to interconnected brain regions in mice.","volume":"126","author":"Rey","year":"2013","journal-title":"Acta neuropathol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/brain\/awv040","article-title":"Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson\u2019s disease brain.","volume":"138","author":"Roberts","year":"2015","journal-title":"Brain"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e930","DOI":"10.1212\/wnl.0000000000012438","article-title":"Diagnostic Value of the CSF \u03b1-Synuclein Real-Time Quaking-Induced Conversion Assay at the Prodromal MCI Stage of Dementia With Lewy Bodies.","volume":"97","author":"Rossi","year":"2021","journal-title":"Neurology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","article-title":"Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies.","volume":"140","author":"Rossi","year":"2020","journal-title":"Acta Neuropathol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/nan.12486","article-title":"Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson\u2019s disease.","volume":"44","author":"Ruffmann","year":"2018","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"35245","DOI":"10.1074\/jbc.M603964200","article-title":"Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification.","volume":"281","author":"Sa\u00e1","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B88","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/35081095","article-title":"Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.","volume":"411","author":"Saborio","year":"2001","journal-title":"Nature"},{"key":"B89","doi-asserted-by":"publisher","first-page":"10732","DOI":"10.1073\/pnas.1321785111","article-title":"Intramuscular injection of \u03b1-synuclein induces CNS \u03b1-synuclein pathology and a rapid-onset motor phenotype in transgenic mice.","volume":"111","author":"Sacino","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B90","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1007\/s12035-017-0624-1","article-title":"Prion-Like Seeding of Misfolded \u03b1-Synuclein in the Brains of Dementia with Lewy Body Patients in RT-QUIC.","volume":"55","author":"Sano","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1039\/b926659c","article-title":"Metalloproteomics and metal toxicology of \u03b1-synuclein.","volume":"2","author":"Santner","year":"2010","journal-title":"Metallomics"},{"key":"B92","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating alpha-synuclein strains in Parkinson\u2019s disease and multiple system atrophy.","volume":"578","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"key":"B93","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","article-title":"Development of a Biochemical Diagnosis of Parkinson Disease by Detection of alpha-Synuclein Misfolded Aggregates in Cerebrospinal Fluid.","volume":"74","author":"Shahnawaz","year":"2017","journal-title":"JAMA Neurol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/nmeth947","article-title":"Direct observation of individual endogenous protein complexes in situ by proximity ligation.","volume":"3","author":"S\u00f6derberg","year":"2006","journal-title":"Nat. Methods"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/brain\/awab005","article-title":"Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder.","volume":"144","author":"Stefani","year":"2021","journal-title":"Brain"},{"key":"B96","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neuint.2017.12.014","article-title":"Pathological role of lipid interaction with \u03b1-synuclein in Parkinson\u2019s disease.","volume":"119","author":"Suzuki","year":"2018","journal-title":"Neurochem. Int."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181fd613b","article-title":"Detection of elevated levels of \u03b1-synuclein oligomers in CSF from patients with Parkinson disease.","volume":"75","author":"Tokuda","year":"2010","journal-title":"Neurology"},{"key":"B98","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00401-016-1661-y","article-title":"Brain-to-stomach transfer of \u03b1-synuclein via vagal preganglionic projections.","volume":"133","author":"Ulusoy","year":"2017","journal-title":"Acta Neuropathol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.pharmthera.2013.01.013","article-title":"Immunotherapy for neurodegenerative diseases: Focus on \u03b1-synucleinopathies.","volume":"138","author":"Valera","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"B100","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/ana.25447","article-title":"alpha-Synuclein real-time quaking-induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism.","volume":"85","author":"van Rumund","year":"2019","journal-title":"Ann. Neurol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous \u03b1-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death.","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"key":"B102","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","article-title":"Anle138b: A novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson\u2019s disease.","volume":"125","author":"Wagner","year":"2013","journal-title":"Acta Neuropathol."},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7596482","article-title":"Blood Plasma of Patients with Parkinson\u2019s Disease Increases Alpha-Synuclein Aggregation and Neurotoxicity.","volume":"2016","author":"Wang","year":"2016","journal-title":"Parkinsons Dis."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamaneurol.2020.3311","article-title":"Skin alpha-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease.","volume":"78","author":"Wang","year":"2020","journal-title":"JAMA Neurol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ejn.13056","article-title":"Oligomeric \u03b1-synuclein and \u03b2-amyloid variants as potential biomarkers for Parkinson\u2019s and Alzheimer\u2019s diseases.","volume":"43","author":"Williams","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"\u03b1-synuclein toxicity in neurodegeneration: Mechanism and therapeutic strategies.","volume":"23","author":"Wong","year":"2017","journal-title":"Nat. Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1093\/brain\/awt131","article-title":"Boosting chaperone-mediated autophagy in vivo mitigates \u03b1-synuclein-induced neurodegeneration.","volume":"136","author":"Xilouri","year":"2013","journal-title":"Brain"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00381","article-title":"The Roles of Post-translational Modifications on \u03b1-Synuclein in the Pathogenesis of Parkinson\u2019s Diseases.","volume":"13","author":"Zhang","year":"2019","journal-title":"Front. Neurosci."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2022.975619\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T05:10:01Z","timestamp":1665378601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2022.975619\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":108,"alternative-id":["10.3389\/fnmol.2022.975619"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2022.975619","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,10]]},"article-number":"975619"}}